DOCSLIB.ORG

Optotic Sperm

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Optotic Sperm US 20110201047Al (19) United States (12) Patent Application Publication (10) Pub. N0.: US 2011/0201047 A1 Paduch (43) Pub. Date: Aug. 18, 2011 (54) NOVEL SORTING TECHNOLOGY THAT (2), (4) Date: Apr. 14, 2011 ALLOWS FOR HIGHLY EFFICIENT . SELECTION OF SPERM WITHOUT Related US. Application Data CHROMATIN DAMAGE (60) Provisional application No. 61/ 105,223, ?led on Oct. 14, 2008. (75) Inventor: Darius A. Paduch, Jersey City, NJ PllblicatiOIl Classi?catiOIl (Us) (51) Int. Cl. C12Q 1/02 (2006.01) (73) Assignee; CORNELL UNIVERSITY, Ithaca, (52) US. Cl. ........................................................ .. 435/29 NY (Us) (57) ABSTRACT This invention provides a method to select and enrich healthy (21) APP1~ N05 13/124,246 sperm for use in assisted reproductive techniques comprising incubating sperm With at least one marking reagent that enters 22 PCT F-I d, 0 L 14 2009 unhealthy sperm but not healthy sperm. The invention also ( ) 1 e c ’ provides a method to sort healthy sperm of high viability from apoptotic, necrotic and dead sperm by using YO-PRO-l and (86) PCT No.: PCT/US09/60636 PI for ?uorescence activated cell sorting in How cytometers. A kit comprising YO-PRO-l and PI is also included in this § 371 (c)(1), invention. 1 ?g; ‘ e2 9 8.5? Nee-mic a nd optotic sperm 0 bIIIE I l‘lll'lll H i Uliil'li m2 t m4 FL1-H Patent Application Publication Aug. 18, 2011 US 2011/0201047 A1 62.9" I as? Némmiic a nd map-Mic ape ---§ FM “stained. 19F ‘ ' PI and M 11 G ‘.1 kahuna I I "!"""i a 1 Hum T mm FIG. v1 US 2011/0201047 A1 Aug. 18,2011 NOVEL SORTING TECHNOLOGY THAT have absorbed the dye are identi?able by the ?uorescence of ALLOWS FOR HIGHLY EFFICIENT the dye and can be separated by knoWn cell-sorting proce SELECTION OF SPERM WITHOUT dures. When YO-PRO-l is used in conjunction With pro CHROMATIN DAMAGE pidium iodide, a Well knoWn ?uorescent marker of dead cells, both apoptotic and dead cells can be identi?ed and removed BACKGROUND from the sperm sample prior to its use in assisted reproductive [0001] Most in vitro fertilization (IVF) failures result from techniques, improving the possibility of successful fertiliza male factor de?ciencies. The quality of sperm is one of the tion, implantation, gestation, and birth of healthy offspring. factors determining the success rate of IVF. The use of ran [0005] The method of the present invention permits reduc domly selected sperm for this procedure can result in various tion of unhealthy sperms in a semen sample, hence enrich anomalies of sperm decondensation and embryonic develop ment of healthy sperms in the same sample. By “reduction of ment. Currently, sperm quality is evaluated by conventional unhealthy sperms”, it is meant that the number of unhealthy semen analysis using a light microscope to determine sperm sperms in a sperm sample or population is reduced by at least concentration, motility and morphology. However, conven tWo (2) fold, at least 3 fold, at least 3 fold, at least 5 fold, at tional semen analysis has limited clinical value for predicting least 6 fold, or at least 7 fold or more. the success rate of IVF as 50% of couples With failed fertili [0006] The advantage of this approach is that the integrity zation have normal pre-IVF semen analysis. Furthermore, of healthy sperms in the sample is preserved, so that the conventional semen analysis does not assess the presence of remaining healthy sperm cells can still be used in assisted apoptotic spermatozoa, Which might be partially responsible reproductive techniques. for the loW fertilization and implantation rates in assisted [0007] The method may be used With human sperms, or reproduction. Sperm chromatin damage may be a negative With sperms from animals such as bulls, stallions, and dogs. predictor for IVF outcomes in couples With recurrent spon taneous abortions and poor embryo development. Methods DEFINITIONS for detecting chromatin damage such as SCSA, TUNEL, Healthy Sperm Halosperrn and Comet assays require permanent ?xation of sperm, making the them unusable for in vitro fertilization or [0008] Healthy sperms refers to sperms that have normal agricultural insemination for livestock and pets. Early apop morphology and motility, are not apoptotic, necrotic, or dead, totic events resulting in chromatin damage are usually accom and are able to produce a fertilized egg naturally or When panied by increased permeability of the cell membrane to introduced to an egg using assisted reproductive techniques. large ions. In this invention, the use of marking reagent is disclosed for ?uorescence activated cell sorting to identify Apoptosis apoptotic sperm With chromatin damage, and sort out healthy [0009] Apoptosis refers broadly to any “programmed cell sperm for use in assisted reproductive technology. death” in Which single or groups of cells that are part of a multicellular organism die in a regulated process. Broadly SUMMARY speaking necrosis is the other form of cell death in a multi [0002] This invention provides a method to select and cellular organism, and is the process by Which cells die under enrich healthy sperms for use in assisted reproduction tech stress, disease, or other attack. niques comprising: a) incubating sperms With at least one [0010] The characteristic morphology of apoptotic cells marking reagent that enters unhealthy sperm cells but not includes increases in the permeability of the plasma mem healthy sperm cells; b) sorting marked sperm cells from brane to Water and large ions, loss of membrane asymmetry unmarked sperm cells. The unhealthy cells can be apoptotic, and attachment, formation of irregular bulges in the cell mem necrotic, or dead. The marking reagents that may be used here brane caused by localized decoupling of the cytoskeleton include ?uorescent dyes such as YO-PRO-l and propidium from the plasma membrane, cell shrinkage, nuclear fragmen iodide (PI). A ?oW cytometer can be used to sort marked tation, chromatin condensation, and chromosomal DNA frag sperm from unmarked sperm. A kit is provided, comprising mentation. Apoptosis is different from necrosis, as the pro YO-PRO-l and propidium iodide (PI). cesses associated With apoptosis in disposal of cellular debris do not damage the organism. BRIEF DESCRIPTION OF THE FIGURES Apoptotic Sperm [0003] FIG. 1: Semen samples from 18 men Were analyzed With propidium iodide (PI) and YO-PRO-l. Dead sperm are [0011] Apoptotic sperms are sperms that are going through permeable to PI, and apoptotic sperm are permeable to YO apopto sis. An early apoptotic event in cells is characterized by PRO-l. Intact cells are impermeable to both. Hoechst 33342 increases in the permeability of plasma membranes and loss Was used to calibrate the BD LSR II ?oW cytometer. Semen of phospholipid asymmetry. Since successful fertilization samples from ?ve patients are sorted With the BD FACS requires a sperm plasma membrane With normal integrity and Vantage. Healthy sperm Were separated from necrotic and function, apoptotic sperm Will have very loW fertility. apoptotic cells based on ?uorochrome staining. Necrosis DETAILED DESCRIPTION [0012] Necrosis refers to the unnatural death of cells and [0004] This invention involves the use of marking reagents living tissue. It begins With cell sWelling, chromatin diges to label unhealthy sperm cells. In particular, apoptotic cells tion, and disruption of the plasma membrane and organelle are permeable by YO-PRO-l, While healthy sperms are not. membranes. Late necrosis is characterized by extensive DNA Necrotic and dead sperms are permeable by propidium iodide hydrolysis, vacuolation of the endoplasmic reticulum, and healthy sperms are not. The unhealthy sperm cells that organelle breakdoWn, and cell lysis. In contrast to apoptosis, US 2011/0201047 A1 Aug. 18,2011 cleanup of cell debris by phagocytes of the immune system is [0030] Gestational Carrier generally more dif?cult, as the disorderly death generally [0031] A gestational carrier is an option When a patient’s does not send signals to nearby phagocytes to engulf the medical condition prevents a safe pregnancy, When a patient dying cell. This lack of signaling makes it harder for the has ovaries but no uterus due to congenital absence or previ immune system to locate and recycle dead cells Which have ous surgical removal, and Where a patient has no ovaries and died through necrosis than if the cell had undergone apopto is also unable to carry a pregnancy to full term. sis. [0032] Cryopreservation [0033] Eggs, sperm and reproductive tissue can be pre Assisted Reproductive Techniques served for later IVF. [0013] Assisted reproductive techniques (ART) is a general [0034] The folloWing Assisted Reproduction techniques term referring to methods used to achieve pregnancy by arti don’t necessarily involve IVF. ?cial or partially arti?cial means. In general, ARTs involve [0035] Gamete intrafallopian transfer (GIFT) surgically removing eggs from a female, obtaining sperm [0036] In gamete intrafallopian transfer a mixture of sperm from a male, combining the egg With sperm in the laboratory, and eggs is placed directly into a Woman’s fallopian tubes and at some point returning the fertilized egg or embryo to a using laparoscopy folloWing a transvaginal ovum retrieval. female body for gestation. ART also include treatments in [0037] Preimplantation Genetic Diagnosis (PGD) Which only sperm are handled (i.e., arti?cial insemination) or [0038] PGD involves the use of Fluorescent In Situ Hybrid procedures in Which a Woman takes medicine only to stimu ization (FISH) or Polymerase Chain Reaction (PCR) DNA late egg production Without the intention of having eggs ampli?cation to help identify genetically abnormal embryos retrieved. and improve healthy outcomes. [0014] When ARTs are used in non-human animals, the [0039] Sex Selection process is generally called arti?cial insemination. [0040] Sex selection is the attempt to control the sex of [0015] Examples of ARTs include, but are not limited to: offspring to achieve a desired sex.
Load more

Recommended publications
  • Goat Polyclonal Antibody Against the Sex Determining Region Y to Separate X- and Y-Chromosome Bearing Spermatozoa
    Reports of Biochemistry & Molecular Biology Vol.8, No.3, Oct 2019 Original article www.RBMB.net Goat Polyclonal Antibody Against the Sex Determining Region Y to Separate X- and Y-Chromosome Bearing Spermatozoa Bijan Soleymani1, Shahram Parvaneh1, Ali Mostafaie*1 Abstract Background: Sex selection of sperm by separating X- and Y-chromosome bearing spermatozoa is critical for efficiently obtaining the desired sex of animal offspring in the livestock industry. The purpose of this study was to produce a goat polyclonal antibody (pAb) against the bovine Sex Determining Region Y chromosome (bSRY) to separate female- and male-bearing spermatozoa. Methods: To produce a goat polyclonal antibody against bSRY, a female goat was subcutaneously immunized with 27 kDa of recombinant bSRY (rbSRY) protein as the antigen. The anti-bSRY pAb was purified by ion-exchange chromatography. The purity of the pAb was determined using the SDS-PAGE method. The biological activity of the anti-bSRY pAb was examined using PCR to assess the binding affinity of pAb for the bSRY antigen and commercially sexed bull sperm. Results: The total amount of purified anti-bSRY pAb was approximately 650 mg/goat serum (13 mg/mL). Interestingly, our data showed that the binding affinity of our pAb to the Y bearing was high, while the binding affinity of that to the X-chromosome bearing sperm was similar to the negative control. Conclusions: In conclusion, our findings show that the goat anti-SRY pAb specifically binds to Y- chromosome bearing sperm that suggesting its potential use for sex selection. Keywords: Polyclonal antibody, Sex determining region Y chromosome, Sperm sexing.
    [Show full text]
  • Microsort® Sperm Sorting Causes No Increase In
    CSIRO PUBLISHING Reproduction, Fertility and Development, 2016, 28, 1580–1587 http://dx.doi.org/10.1071/RD15011 Ò MicroSort sperm sorting causes no increase in major malformation rate Donald P. MarazzoA,C,D, David KarabinusA, Lawrence A. JohnsonB and Joseph D. SchulmanA AGenetics and IVF Institute, 3015 Williams Drive, Fairfax, VA 22031, USA. BU.S. Department of Agriculture, 10300 Baltimore Ave, Bldg. 200, BARC-East Beltsville, MD 20705, USA. CInstitute for Healthy Reproductive Outcomes, 355 S Highland Avenue, Pittsburgh, PA 15206, USA. DCorresponding author. Email: [email protected] Abstract. The purpose of the present study was to evaluate the safety of MicroSort (MicroSort Division, GIVF, Fairfax, VA, USA) sperm sorting by monitoring major malformations in infants and fetuses conceived using sorted spermatozoa. Data were collected in a prospective protocol with monitoring that began from conception through birth until 1 year of life. Comprehensive ascertainment identified fetuses and stillbirths with malformations after 16 weeks gestation, pregnancies terminated for malformations and babies with major malformations. Outcomes in MicroSort pregnancies were compared with outcomes in published studies that used active and comprehensive ascertainment of malformations in the general population and in pregnancies established after assisted reproduction. Using comprehensive outcomes from all pregnancies, the rate of major malformations in MicroSort pregnancies conceived after IVF with or without intracyto- plasmic sperm injection was 7.8%; this did not differ significantly from the rates reported in the three assisted reproductive technology control studies not associated with MicroSort (8.6%, 9.2% and 8.3%). Similarly, the rate of major malformations in MicroSort pregnancies initiated with intrauterine insemination was 6.0%, not significantly different from that reported in non-assisted reproductive technology pregnancies not associated with MicroSort (6.9%, 4.6% and 5.7%).
    [Show full text]
  • Mini–Review Article
    Advances in Animal and Veterinary Sciences 2 (4): 226 – 232 http://dx.doi.org/10.14737/journal.aavs/2014/2.4.226.232 Mini–Review Article Sexing of Spermatozoa in Farm Animals: a Mini Review Mani Arul Prakash1, Arumugam Kumaresan1*, Ayyasamy Manimaran1, Rahul Kumar Joshi1, Siddhartha Shankar Layek1, Tushar Kumar Mohanty1, Ravi Ram Divisha 2 1Theriogenology Laboratory, National Dairy Research Institute, Karnal – 132 001 Haryana; 2Division of Veterinary Pharmacology, College of Veterinary Sciences, Rajendra Nagar, Hyderabad – 500 030, Andhra Pradesh *Corresponding author: [email protected] ARTICLE HISTORY ABSTRACT Received: 2014 – 03 – 26 Livestock farmers always have a wish for producing young ones of desired sex. Among the Revised: 2014 – 04 – 11 several techniques available, use of sexed semen for artificial insemination is recognized as Accepted: 2014 – 04 – 12 more pragmatic and easy way to pre – select the sex of the offspring. Selective use of sexed semen in breeding will not only increase the genetic progress from the daughter – dam path but would also help in producing good male germplasm from elite bulls for future breeding. Key Words: Sex – sorting, Several attempts have been made, elsewhere in the globe, to develop methods that efficiently Spermatozoa, Farm animals, separate bovine semen into fractions containing higher concentrations of X – or Y – bearing Flow cytometry sperm. These technologies include sex specific antibodies, centrifugation and flow cytometry. Of these attempts, the only method proven to be commercially viable is flow cytometry. However, sorting pressure, speed, electrical deviation, laser radiation all leads to membrane alteration and pre – capacitation like changes in the sorted sperm leading to reduced fertility.
    [Show full text]
  • Successful Selection of Mouse Sperm with High Viability and Fertility Using
    www.nature.com/scientificreports OPEN Successful selection of mouse sperm with high viability and fertility using microfuidics chip cell sorter Satohiro Nakao1, Toru Takeo1 ✉ , Hitomi Watanabe2, Gen Kondoh2 & Naomi Nakagata1 Cell sorting via fow cytometry is a powerful tool to select subpopulations of cells in many biological felds. Selection of fertilisation-prone sperm is a critical step to ensure a stable and high fertilisation rate in in vitro fertilisation (IVF). However, a combination of conventional cell sorting and IVF system has not been established because of severe mechanical damages to the sperm during the sorting process. A cell sorter with microfuidics chip technology that lessens cell damage during cell sorting may address this problem. We evaluated the efects of microfuidics chip cell sorting on the sperm using the parameters, such as motility and fertility, and found this cell sorting method had minimal harmful efect on the sperm. Then, sperm were selected by a marker for acrosome reaction and showed higher fertilisation rate than that of the population of acrosome-intact sperm. Embryo derived from these sperm developed normally. These results indicated that microfuidics chip cell sorting can select fertile sperm to improve IVF technique. Selection of fertile sperm is a key step in obtaining a stable and high fertilisation rate in in vitro fertilisation (IVF). Sperm selection is generally performed according to motility, morphological integrity and specifc gravity, using the swim-up method and density gradient centrifugation1–4. Terefore, with the aim of improving the IVF tech- nology, we wanted to employ other methods such as sperm sorting as well as conventional methods.
    [Show full text]
  • The Effectiveness of Flow Cytometric Sorting of Human Sperm (Microsort®) for Influencing a Child's
    Karabinus et al. Reproductive Biology and Endocrinology 2014, 12:106 http://www.rbej.com/content/12/1/106 RESEARCH Open Access The effectiveness of flow cytometric sorting of human sperm (MicroSort®) for influencing a child’s sex David S Karabinus1*, Donald P Marazzo1, Harvey J Stern1, Daniel A Potter2, Chrispo I Opanga1, Marisa L Cole1, Lawrence A Johnson3 and Joseph D Schulman1 Abstract Background: Flow cytometric sorting can be used to separate sperm based on sex chromosome content. Differential fluorescence emitted by stained X- vs. Y-chromosome-bearing sperm enables sorting and collection of samples enriched in either X- or Y-bearing sperm for use to influence the likelihood that the offspring will be a particular sex. Herein we report the effectiveness of flow cytometric sorting of human sperm and its use in human ART procedures. Methods: This prospective, observational cohort study of the series of subjects treated with flow cytometrically sorted human sperm was conducted at investigational sites at two private reproductive centers. After meeting inclusion criteria, married couples (n = 4993) enrolled to reduce the likelihood of sex-linked or sex-limited disease in future children (n = 383) or to balance the sex ratio of their children (n = 4610). Fresh or frozen-thawed semen was processed and recovered sperm were stained with Hoechst 33342 and sorted by flow cytometry (n = 7718) to increase the percentage of X-bearing sperm (n = 5635) or Y-bearing sperm (n = 2083) in the sorted specimen. Sorted sperm were used for IUI (n = 4448) and IVF/ICSI (n = 2957). Measures of effectiveness were the percentage of X- and Y-bearing sperm in sorted samples, determined by fluorescence in situ hybridization, sex of babies born, IVF/ICSI fertilization- and cleavage rates, and IUI, IVF/ICSI, FET pregnancy rates and miscarriage rates.
    [Show full text]
  • Biological and Practical Lessons Associated with the Use of Sexed Semen
    Lessons associated with the use of sexed semen 507 Biological and practical lessons associated with the use of sexed semen Simon P. de Graaf1, Tamara Leahy1 and Ramakrishnan Vishwanath2 1Faculty of Veterinary Science, The University of Sydney NSW 2006 Australia; 2Sexing Technologies, 22575 State Hwy 6 Sth, Navasota, Texas, USA Summary Numerous biological and practical lessons associated with the use of sexed semen have been learnt in the 15 years since it was released onto the commercial market. Over this time, concerns regarding the safety of sex-sorted spermatozoa have been largely allayed through the birth of several million pre-sexed calves, but the major issue that remains is that of reduced fertility. Numerous studies have demonstrated that the process of flow cytometric sorting and subsequent cryopreservation causes reduced in vitro and in vivo fertility of sexed semen, which cannot be wholly compensated for by increasing the number of spermatozoa inseminated. As a result of this diminished fertilising capacity, the use of sex-sorted bull spermatozoa was traditionally only recommended for insemination of heifers, not lactating, superovulated and/or synchronised animals due to the low fertility obtained. However, recent changes to the processing methods used during and after flow-sorting are showing the fertility of ‘sexed semen’ is improving for the first time in over a decade of commercial activity. With continued research and development of methods to improve the conditions under which spermatozoa are sorted and frozen and concurrent advancements in sorter technology, it is anticipated that the fertility and application of sexed semen will continue to increase. Introduction It is now almost three decades since sex-preselection of offspring was proven possible with the birth of a litter of female rabbit kits (Johnson et al.
    [Show full text]
  • Antibody for Determining Sex of Sperm, and Use Thereof
    (19) TZZ¥¥ ¥ _T (11) EP 3 323 828 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 153(4) EPC (43) Date of publication: (51) Int Cl.: 23.05.2018 Bulletin 2018/21 C07K 14/705 (2006.01) C07K 16/28 (2006.01) G01N 33/53 (2006.01) A01K 67/02 (2006.01) (21) Application number: 16824713.8 (86) International application number: (22) Date of filing: 13.07.2016 PCT/KR2016/007582 (87) International publication number: WO 2017/010796 (19.01.2017 Gazette 2017/03) (84) Designated Contracting States: (71) Applicants: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • Kim, Dong Ku GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO Seoul 01603 (KR) PL PT RO RS SE SI SK SM TR • Nuriscience Co., Ltd. Designated Extension States: Seoul 05053 (KR) BA ME Designated Validation States: (72) Inventor: Kim, Dong Ku MA MD Seoul 01603 (KR) (30) Priority: 13.07.2015 KR 20150099080 (74) Representative: Brevalex 12.07.2016 KR 20160088170 56, Boulevard de l’Embouchure B.P. 27519 31075 Toulouse Cedex 2 (FR) (54) ANTIBODY FOR DETERMINING SEX OF SPERM, AND USE THEREOF (57) The present invention relates to an antibody for an agglutination reaction of Y-chromosome bearing determining the sex of a sperm, and a use thereof and, sperm through the treatment of the antibody, and thus more particularly, to a composition for determining the customized animals having a particular sex can be sex of a sperm, a method for determining sex, and a mass-produced.
    [Show full text]
  • Sex Selection: Sorting Sperm As a Gateway to the Sorting Society? Edgar Dahl
    3 Sex selection: sorting sperm as a gateway to the sorting society? Edgar Dahl Since ancient times, couples have been trying to influence the sex of their children. Following a suggestion by Aristotle, they were making love in the north wind to ensure the birth of a son and in the south wind to ensure the birth of a daughter. According to a proposal made by Galen, men were tying a string around their left testicle to make a boy and tying the right one to make a girl. In medieval times the proposed formula got even more bizarre when alchemists recommended to drink the blood of a lion and then have intercourse under a full moon to sire a son.1 Choosing the sex of our children is no longer a fantasy. However, the prospect of a reliable method for sex selection has not only raised old hopes, but also new fears. Many people are concerned that it may lead to an imbalance of the sexes, most likely a preponderance of males. Such an overabundance of men and a shortage of women, some sociologists have predicted, will invariably cause an enormous rise in enforced celibacy, polyandry, homosexuality, prostitution, rape and other sexual crimes.2 Many feminists are similarly alarmed. Some have called the deliberate choice of a male child ‘the original sexist sin’.3 Others went so far as to warn us of an impending ‘gynocide’.4 Are these fears justified? How well are they supported by empirical evidence? And most of all: does sex selection call for a legal ban? Before turning to these questions, let us briefly review the state of the art.
    [Show full text]
  • Sex Selection for Nonhealth-Related Reasons Commentary by Lusine Aghajanova, MD, Phd, and Cecilia T
    Virtual Mentor American Medical Association Journal of Ethics February 2012, Volume 14, Number 2: 105-111. CLINICAL CASE Sex Selection for Nonhealth-Related Reasons Commentary by Lusine Aghajanova, MD, PhD, and Cecilia T. Valdes, MD Mr. and Mrs. Carter had been married for 6 years when they visited Dr. Jones, a well-known infertility specialist, to ask for help creating their family. Mrs. Carter had given birth to a beautiful, healthy baby girl 3 years earlier. She was the light of their lives, and they loved her dearly. Now that their daughter was in preschool, they had decided it was time for them to complete their family by having another child—a son. They sat down in the plush chairs in Dr. Jones’s office. Mr. Carter spoke first, “We’ve done a lot of research, Dr. Jones, and we think you can help us. A couple that we are friends with came to you to make sure they had a girl, since they have a disease in their family that runs in boys. We’re here to see if you can help us conceive a son for our family.” Dr. Jones was confused about what they were asking for, and why. “Have you been having trouble getting pregnant?” he asked Mrs. Carter. “Oh, no,” she responded. “We haven’t been trying. We wanted to wait to see you, so that we could make sure we had a boy. We love our daughter, and we always thought it would be perfect to have one of each. A balanced family.” “Hmm,” Dr.
    [Show full text]
  • Journal of Pharma Research
    S.M.S. Nikhil, et al. J Pharm Res, 2018;7(12):290-294 World Inventia Publishers Journal of Pharma Research http://www.jprinfo.com/ Vol. 7, Issue 12, 2018 ISSN: 2319-5622 USA CODEN: JPROK3 Review Article SPERM SORTING - A COMPHRAHENSIVE REVIEW S.M.S. Nikhil *, Sarvan Kumar G 1, Dr. Kiran Kumar Y 2, Dr. P. Venakateswar Rao 3, Dr. Ramesh Adepu 4 * Department of Pharm.D, Vikas College of Pharmaceutical Sciences, Rayanigudem, Suryapet, Telangana, INDIA. 1Department of Pharmacology, Vikas College of Pharmaceutical Sciences, Rayanigudem, Suryapet, Telangana, INDIA. 2Department of Pharmaceutics, Vikas College of Pharmaceutical Sciences, Rayanigudem, Suryapet, Telangana, INDIA. 3Department of Medicinical Chemistry, Vikas College of Pharmaceutical Sciences, Rayanigudem, Suryapet, Telangana, INDIA. 4Department of Pharmacy Practice, Vikas College of Pharmaceutical Sciences, Rayanigudem, Suryapet, Telangana, INDIA. Received on: 07-11-2018; Revised and Accepted on: 18-12-2018 ABSTRACT The sex of mammalian offspring can be predetermined by flow sorting relatively pure living populations of X and Y-chromosome bearing sperm. This method is based on precise staining of DNA of sperm with the nucliecacid specific fluorospore, Hoechst 33342, to differentiate between the subpopulations of X and Y sperm. The fluoroscently stained sperm are then sex sorted using a specialised high speed sorter, MoFlo SX XDP, and collected into biologically supportive media prior to reconcentration and cryopreservation in numbers adequate for use with artificial insemination for some species or for invitro fertilization. Sperm sorting can provide subpopulations of X- or Y-bearing bovine sperm at rates in the 8000 sperms/s range while maintaining; a purity of 90% such that it has been applied to cattle on a commercial basis.
    [Show full text]
  • Game-Changing Approaches in Sperm Sex-Sorting: Microfluidics and Nanotechnology
    animals Review Game-Changing Approaches in Sperm Sex-Sorting: Microfluidics and Nanotechnology Andra-Sabina Neculai-Valeanu 1,2,* and Adina Mirela Ariton 1 1 Research and Development Station for Cattle Breeding Dancu, 707252 Iasi, Romania; [email protected] 2 Department of Fundamental Sciences in Animal Husbandry, Faculty of Food and Animal Sciences, University of Applied Life Sciences and Environment “Ion Ionescu de la Brad”, 700490 Iasi, Romania * Correspondence: [email protected] Simple Summary: Sexing of sperm cells, including the capacity to preselect the sex of offspring prior to reproduction, has been a major target of reproductive biotechnology for a very long time. The advances in molecular biology, biophysics, and computer science over the past few decades, as well as the groundbreaking new methods introduced by scientists, have contributed to some major breakthroughs in a variety of branches of medicine. In particular, assisted reproduction is one of the areas in which emerging technologies such as nanotechnology and microfluidics may enhance the fertility potential of samples of sex-sorted semen, thus improving the reproductive management of farm animals and conservation programs. In human medicine, embryo sex-selection using in vitro fertilization (IVF) and preimplantation genetic testing (PGT) is accepted only for medical reasons. Using sex-sorting before IVF would enable specialists to prevent sex-linked genetic diseases and prevent the discharge of embryos which are not suitable for transfer due to their sex. Abstract: The utilization of sex-sorted sperm for artificial insemination and in-vitro fertilization Citation: Neculai-Valeanu, A.-S.; Ariton, A.M. Game-Changing is considered a valuable tool for improving production efficiency and optimizing reproductive Approaches in Sperm Sex-Sorting: management in farm animals, subsequently ensuring sufficient food resource for the growing human Microfluidics and Nanotechnology.
    [Show full text]
  • SENATE BILL 400 by Hensley an ACT to Amend Tennessee Code
    SENATE BILL 400 By Hensley AN ACT to amend Tennessee Code Annotated, Title 36, relative to the donation of eggs and sperm. BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE: SECTION 1. Tennessee Code Annotated, Title 36, is amended by adding the following as a new chapter: 36-8-101. This act shall be known and may be cited as the “Egg Guidelines and Governance and Sperm Provider Effective Record Management (EGG and SPERM) Act.” 36-8-102. For purposes of this chapter: (1) “Altruistic surrogacy” means a surrogacy agreement in which the surrogate receives compensation equal to or less than the reimbursement of medical and other reasonable expenses; (2) “ART program” means any treatment program or entity providing procedures involving assisted reproductive technology; (3) “Assisted reproductive technology” or “ART”: (A) Means clinical treatments and laboratory procedures that include the handling of human eggs and sperm, or embryos, with the intent of establishing a pregnancy; and (B) Includes in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), and any other assisted reproductive technologies recognized by the department; (4) “Biological surrogacy” means a surrogacy arrangement using the surrogate’s own oocyte; SB0400 001389 -1- (5) “Commercial surrogacy” means a surrogacy agreement in which the surrogate receives compensation beyond the reimbursement of medical and other reasonable expenses; (6) “Commissioner” means the commissioner of health; (7) “Department” means the
    [Show full text]